Hematology/Oncology

Top Story

CDC annual report: Prescription drug use, obesity rates increase

June 28, 2017

Life expectancy is up and tobacco use is down, but there are still several concerning health indicators in the CDC’s 40th annual report on long-term trends in health and health care delivery of the nation between 1975 and 2015 which was delivered from the Secretary of HHS to President Donald Trump and Congress.

The report, Health, United States, 2016, describes birth rates and infant mortality, life expectancy and leading causes of death, health risk behaviors, health care utilization and insurance coverage and health expenditures. Highlights from the report include declines in cigarette smoking, increases in prescription drug use and changes in expenditures for hospitals and home health care. The CDC also investigated population changes that have affected patterns of disease and health care access and utilization since 1975.

Meeting News

Ixazomib combination confers durable responses in newly diagnosed myeloma

June 28, 2017
A combination regimen of ixazomib plus lenalidomide and dexamethasone conferred deep and durable responses among patients with newly diagnosed multiple myeloma…
Meeting News

Enzalutamide enhances PSA response, but not time to PSA progression, vs. abiraterone

June 28, 2017
CHICAGO – Enzalutamide demonstrated a greater PSA response among patients with metastatic, castration-resistant prostate cancer than abiraterone, although time to…

ACP: Supreme Court permitting parts of travel ban ‘creates uncertainty’

June 28, 2017
The June 26 Supreme Court decision to allow parts of President Trump’s travel ban on six Muslim-majority countries to take effect generates uncertainty and…
Meeting News

Enzyme activator could be ‘disease-altering’ treatment for pyruvate kinase deficiency

June 28, 2017
Enzyme activator AG-348 sustained hemoglobin increases in adults with pyruvate kinase deficiency, according to updated data from a phase 2 trial presented at the…
More News Headlines »
CNE CME

The Identification and Management of Immune-related Adverse Events in Patients with Cancer: Practice Essentials for Emergency Medicine Providers

This activity is supported by an educational grant from Bristol-Myers Squibb.

The incorporation of immunotherapies, especially the immune checkpoint inhibitors, into treatment regimens for patients…
More »
Video
Meeting News

VIDEO: Results of LATITUDE trial reinforce long-hypothesized theory in prostate cancer treatment

June 21, 2017
More »
Resource Centers

CME

Breakthroughs in the Treatment of Bladder Cancer

This activity is supported by an educational grant from Bristol-Myers Squibb.

Assessment of immune checkpoint blockade inhibitors in the treatment of bladder cancer have demonstrated significant…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement